Stewart, D A <br/><br/>
Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation.  [electronic resource] 

 -  Bone marrow transplantation  Aug 2000 
 - 383-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1702541  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Blood Component Removal--methods<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Etoposide--administration & dosage<br/>Follow-Up Studies<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Multivariate Analysis<br/>Proportional Hazards Models<br/>Risk Factors<br/>Survival Rate<br/>Transplantation, Autologous--methods<br/>Treatment Outcome